SEC Form 5 · accession 0001570523-18-000018
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 30, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Aug 15, 2016 | P | 1,000 | $0.118 | A | 20,800,359 | D | |
| Common stock | Aug 16, 2016 | P | 6,000 | $0.112 | A | 20,800,359 | D | |
| Common stock | Aug 16, 2016 | P | 1,000 | $0.111 | A | 20,800,359 | D | |
| Common stock | Aug 16, 2016 | P | 5,000 | $0.111 | A | 20,800,359 | D | |
| Common stock | Aug 16, 2016 | P | 1,100 | $0.111 | A | 20,800,359 | D | |
| Common stock | Aug 17, 2016 | P | 1,000 | $0.112 | A | 20,800,359 | D | |
| Common stock | Aug 17, 2016 | P | 1,000 | $0.112 | A | 20,800,359 | D | |
| Common stock | Aug 24, 2016 | P | 2,000 | $0.11 | A | 20,800,359 | D | |
| Common stock | Aug 25, 2016 | P | 1,000 | $0.111 | A | 20,800,359 | D | |
| Common stock | Aug 26, 2016 | P | 5,000 | $0.1149 | A | 20,800,359 | D | |
| Common stock | Aug 26, 2016 | P | 5,200 | $0.115 | A | 20,800,359 | D | |
| Common stock | Aug 26, 2016 | P | 1,200 | $0.115 | A | 20,800,359 | D | |
| Common stock | Aug 26, 2016 | P | 1,000 | $0.118 | A | 20,800,359 | D | |
| Common stock | Aug 26, 2016 | P | 1,000 | $0.12 | A | 20,800,359 | D | |
| Common stock | Sep 2, 2016 | P | 30,000 | $0.11 | A | 20,800,359 | D | |
| Common stock | Sep 2, 2016 | P | 10,000 | $0.11 | A | 20,800,359 | D | |
| Common stock | Sep 2, 2016 | P | 9,000 | $0.11 | A | 20,800,359 | D | |
| Common stock | Sep 2, 2016 | P | 1,000 | $0.12 | A | 20,800,359 | D | |
| Common stock | Sep 2, 2016 | P | 1,000 | $0.10 | A | 20,800,359 | D | |
| Common stock | Sep 2, 2016 | P | 20,000 | $0.10 | A | 20,800,359 | D | |
| Common stock | Sep 2, 2016 | P | 1,000 | $0.12 | A | 20,800,359 | D | |
| Common stock | Sep 9, 2016 | P | 1,000 | $0.118 | A | 20,800,359 | D | |
| Common stock | Sep 9, 2016 | P | 3,000 | $0.13 | A | 20,800,359 | D | |
| Common stock | Sep 12, 2016 | P | 1,000 | $0.12 | A | 20,800,359 | D | |
| Common stock | Sep 13, 2016 | P | 1,000 | $0.1245 | A | 20,800,359 | D | |
| Common stock | Sep 16, 2016 | P | 1,000 | $0.1045 | A | 20,800,359 | D | |
| Common stock | Sep 19, 2016 | P | 2,260 | $0.103 | A | 20,800,359 | D | |
| Common stock | Sep 27, 2016 | P | 1,000 | $0.099 | A | 20,800,359 | D | |
| Common stock | Sep 27, 2016 | P | 10,000 | $0.10 | A | 20,800,359 | D | |
| Common stock | Sep 27, 2016 | P | 20,000 | $0.105 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 14 of 16 submissions.